FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
TG Therapeutics (NASDAQ: TGTX) reported Q2 EPS of ($0.30), $0.21 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $594 thousand versus the consensus estimate of $175.43 thousand.
For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.
... More
